PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 32364269-7 2021 All AmpC and/or ESBL-phenotype E. coli were sensitive to colistin, ertapenem, imipenem, meropenem, temocillin and tigecycline, applying epidemiological cut-off values. Tigecycline 114-125 beta-lactamase Escherichia coli 4-8 18077630-0 2008 Treatment with tigecycline of recurrent urosepsis caused by extended-spectrum-beta-lactamase-producing Escherichia coli. Tigecycline 15-26 beta-lactamase Escherichia coli 78-92 21325253-1 2011 This study evaluated the activity of tigecycline combined with imipenem, amikacin, and ciprofloxacin against clinical isolates of multidrug-resistant Klebsiella pneumoniae and Escherichia coli co-producing extended-spectrum beta-lactamases and acquired AmpC beta-lactamases. Tigecycline 37-48 beta-lactamase Escherichia coli 253-257